Literature DB >> 21045195

CTLs respond with activation and granule secretion when serving as targets for T-cell recognition.

Oren Milstein1, David Hagin, Assaf Lask, Shlomit Reich-Zeliger, Elias Shezen, Eran Ophir, Yaki Eidelstein, Ran Afik, Yaron E Antebi, Michael L Dustin, Yair Reisner.   

Abstract

Cytotoxic T lymphocytes (CTLs) suppress T cell responses directed against their antigens regardless of their own T cell receptor (TCR) specificity. This makes the use of CTLs promising for tolerance induction in autoimmunity and transplantation. It has been established that binding of the CTL CD8 molecule to the major histocompatibility complex (MHC) class I α3 domain of the recognizing T cell must be permitted for death of the latter cell to ensue. However, the signaling events triggered in the CTL by this molecular interaction in the absence of TCR recognition have never been clarified. Here we use single-cell imaging to study the events occurring in CTLs serving as targets for recognition by specific T cells. We demonstrate that CTLs actively respond to recognition by polarizing their cytotoxic granules to the contact area, releasing their lethal cargo, and vigorously proliferating. Using CTLs from perforin knockout (KO) mice and lymphocyte specific kinase (Lck) knockdown with specific small interfering RNA (siRNA), we show that the killing of the recognizing CD8 T cell is perforin dependent and is initiated by Lck signaling in the CTL. Collectively, these data suggest a novel mechanism in which the entire cascade generally triggered by TCR engagement is "hijacked" in CTLs serving as targets for T cell recognition without TCR ligation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21045195      PMCID: PMC3035066          DOI: 10.1182/blood-2010-05-283770

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  52 in total

1.  Programmed cell death of T cells signaled by the T cell receptor and the alpha 3 domain of class I MHC.

Authors:  S R Sambhara; R G Miller
Journal:  Science       Date:  1991-06-07       Impact factor: 47.728

2.  Inability of CD8 alpha' polypeptides to associate with p56lck correlates with impaired function in vitro and lack of expression in vivo.

Authors:  R Zamoyska; P Derham; S D Gorman; P von Hoegen; J B Bolen; A Veillette; J R Parnes
Journal:  Nature       Date:  1989-11-16       Impact factor: 49.962

Review 3.  Veto cells.

Authors:  P J Fink; R P Shimonkevitz; M J Bevan
Journal:  Annu Rev Immunol       Date:  1988       Impact factor: 28.527

4.  Cloned cytolytic T cells can suppress primary cytotoxic responses directed against them.

Authors:  P J Fink; H G Rammensee; M J Bevan
Journal:  J Immunol       Date:  1984-10       Impact factor: 5.422

5.  An immunological suppressor cell inactivating cytotoxic T-lymphocyte precursor cells recognizing it.

Authors:  R G Miller
Journal:  Nature       Date:  1980-10-09       Impact factor: 49.962

6.  T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1.

Authors:  M L Dustin; T A Springer
Journal:  Nature       Date:  1989-10-19       Impact factor: 49.962

7.  The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosine-protein kinase p56lck.

Authors:  A Veillette; M A Bookman; E M Horak; J B Bolen
Journal:  Cell       Date:  1988-10-21       Impact factor: 41.582

8.  Kidney allograft tolerance in primates without chronic immunosuppression--the role of veto cells.

Authors:  J M Thomas; F M Carver; P R Cunningham; L C Olson; F T Thomas
Journal:  Transplantation       Date:  1991-01       Impact factor: 4.939

9.  Functional heterogeneity in allospecific cytotoxic T lymphocyte clones. I. CTL clones express strong anti-self suppressive activity.

Authors:  M H Claësson; R G Miller
Journal:  J Exp Med       Date:  1984-12-01       Impact factor: 14.307

10.  The strength of T cell receptor signal controls the polarization of cytotoxic machinery to the immunological synapse.

Authors:  Misty R Jenkins; Andy Tsun; Jane C Stinchcombe; Gillian M Griffiths
Journal:  Immunity       Date:  2009-10-16       Impact factor: 43.474

View more
  16 in total

1.  Th1 Immune Response Induction by Biogenic Selenium Nanoparticles in Mice with Breast Cancer: Preliminary Vaccine Model.

Authors:  Mohammad Hossein Yazdi; Mehdi Mahdavi; Elnaz Faghfuri; Mohammad Ali Faramarzi; Zargham Sepehrizadeh; Zuhair Mohammad Hassan; Mehdi Gholami; Ahmad Reza Shahverdi
Journal:  Iran J Biotechnol       Date:  2015-06       Impact factor: 1.671

Review 2.  T Cells and Regulated Cell Death: Kill or Be Killed.

Authors:  Johan Spetz; Adam G Presser; Kristopher A Sarosiek
Journal:  Int Rev Cell Mol Biol       Date:  2018-08-29       Impact factor: 6.813

3.  The role of donor-derived veto cells in nonmyeloablative haploidentical HSCT.

Authors:  N Or-Geva; Y Reisner
Journal:  Bone Marrow Transplant       Date:  2015-06       Impact factor: 5.483

4.  Genome-Wide DNA Methylation Profiling in CD8 T-Cells and Gamma Delta T-Cells of Asian Indian Patients With Takayasu Arteritis.

Authors:  Jayakanthan Kabeerdoss; Debashish Danda; Ruchika Goel; Hindhumathi Mohan; Sumita Danda; R Hal Scofield
Journal:  Front Cell Dev Biol       Date:  2022-06-23

Review 5.  The Cancer Immunogram as a Framework for Personalized Immunotherapy in Urothelial Cancer.

Authors:  Nick van Dijk; Samuel A Funt; Christian U Blank; Thomas Powles; Jonathan E Rosenberg; Michiel S van der Heijden
Journal:  Eur Urol       Date:  2018-09-28       Impact factor: 20.096

6.  Murine anti-third-party central-memory CD8(+) T cells promote hematopoietic chimerism under mild conditioning: lymph-node sequestration and deletion of anti-donor T cells.

Authors:  Eran Ophir; Noga Or-Geva; Irina Gurevich; Orna Tal; Yaki Eidelstein; Elias Shezen; Raanan Margalit; Assaf Lask; Guy Shakhar; David Hagin; Esther Bachar-Lustig; Shlomit Reich-Zeliger; Andreas Beilhack; Robert Negrin; Yair Reisner
Journal:  Blood       Date:  2012-12-05       Impact factor: 22.113

Review 7.  Therapeutic targeting of the inflammome.

Authors:  Kyle T Wright; Charles Giardina; Anthony T Vella
Journal:  Biochem Pharmacol       Date:  2014-09-06       Impact factor: 5.858

8.  Expression of Programmed Death-Ligand 1 in Laryngeal Carcinoma and its Effects on Immune Cell Subgroup Infiltration.

Authors:  Dan Yu; Jinzhang Cheng; Kai Xue; Xue Zhao; Lianji Wen; Chengbi Xu
Journal:  Pathol Oncol Res       Date:  2018-10-25       Impact factor: 3.201

9.  The use of donor-derived veto cells in hematopoietic stem cell transplantation.

Authors:  Eran Ophir; Yair Reisner
Journal:  Front Immunol       Date:  2012-05-02       Impact factor: 7.561

10.  Tubulin and actin interplay at the T cell and antigen-presenting cell interface.

Authors:  Noa Beatriz Martín-Cófreces; Balbino Alarcón; Francisco Sánchez-Madrid
Journal:  Front Immunol       Date:  2011-07-04       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.